Viewing Study NCT01386359


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-01 @ 7:58 PM
Study NCT ID: NCT01386359
Status: COMPLETED
Last Update Posted: 2022-06-06
First Post: 2011-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module